Background: The serine/threonine kinase PIM2 is highly expressed in human leukemia and lymphomas and has been shown to positively regulate survival and proliferation of tumor cells. Its diverse ATP site makes PIM2 a promising target for the development of anticancer agents. To date our knowledge of catalytic domain structures of the PIM kinase family is limited to PIM1 which has been extensively studied and which shares about 50% sequence identity with PIM2.
Principal Findings: Here we determined the crystal structure of PIM2 in complex with an organoruthenium complex (inhibition in sub-nanomolar level). Due to its extraordinary shape complementarity this stable organometallic compound is a highly potent inhibitor of PIM kinases.
Significance: The structure of PIM2 revealed several differences to PIM1 which may be explored further to generate isoform selective inhibitors. It has also demonstrated how an organometallic inhibitor can be adapted to the binding site of protein kinases to generate highly potent inhibitors.
Enhanced Version: This article can also be viewed as an enhanced version in which the text of the article is integrated with interactive 3D representations and animated transitions. Please note that a web plugin is required to access this enhanced functionality. Instructions for the installation and use of the web plugin are available in Text S1.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743286 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007112 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
A putative mycobacterial GDP-mannose dependent α-mannosyltransferase Rv0225 acts as PimC: an study.
J Biomol Struct Dyn
December 2024
Department of Bioscience and Biotechnology, Indian Institute of Technology Kharagpur, Kharagpur, India.
The complex cell envelope of pathogenic mycobacteria provides a strong barrier against the host immune system and various antibiotics. Phosphatidyl-myo-inositol mannosides (PIMs), lipomannan (LM), and lipoarabinomannan (LAM) are structurally important elements of mycobacterial cell envelope and also play crucial roles in modulating the host immune functions. At the cytoplasmic side of the mycobacterial inner membrane, phosphatidyl-myo-inositol (PI) is mannosylated by α-mannosyltransferases PimA and PimB' to synthesize PIM using GDP-mannose (GDPM) as the mannose donor.
View Article and Find Full Text PDFHeterocycle-functional steroidal derivatives: Design, synthesis, bioevaluation and SARs of steroidal pyrazolo[1,5-a]pyrimidines as potential ALK inhibitors.
Bioorg Chem
December 2024
Key Laboratory of Microbial Pesticides, Ministry of Agriculture and Rural Affairs, National Biopesticide Engineering Research Centre, Hubei Biopesticide Engineering Research Centre, Hubei Academy of Agricultural Sciences, Wuhan 430064, China. Electronic address:
Two series of heterocyclic steroidal pyrazolo[1,5-a]pyrimidines derived from dehydroepiandrosterone (DHEA) and epiandrosterone (EPIA) were designed and synthesized, and these compounds were screened for their potential antiproliferation activities. The preliminary bioassay indicated that some of target compounds exhibited significantly good antiproliferation activities against human melanoma cell line (A875) and human hepatocellular carcinoma (Huh-7) cell lines compared with 5-fluorouracil (5-FU), and some of which present good antiproliferative activities as potential ALK inhibitors. The detailed analysis of structure-activity relationships (SARs) based on the inhibition activities, kinase assay, and molecular docking demonstrated that the antiproliferation activities of these steroidal pyrazolo[1,5-a]pyrimidine might be affected by the β-hydroxyl group of steroidal scaffold and the N atom of pyridine heterocycle.
View Article and Find Full Text PDFPIM Kinase Inhibitors as Novel Promising Therapeutic Scaffolds in Cancer Therapy.
Curr Top Med Chem
November 2024
Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata - Group of Institutions, 124, B.L Saha Road, Kolkata 700053, West Bengal, India.
Cancer involves the uncontrolled, abnormal growth of cells and affects other tissues. Kinase has an impact on proliferating the cells and causing cancer. For the purpose of treating cancer, PIM kinase is a potential target.
View Article and Find Full Text PDFIdentification of potential PIM-2 inhibitors via ligand-based generative models, molecular docking and molecular dynamics simulations.
Mol Divers
August 2024
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Proviral Integrations of Moloney-2 (PIM-2) kinase is a promising target for various cancers and other diseases, and its inhibitors hold potential for treating related diseases. However, there is currently no clinically available PIM-2 inhibitor. In this study, we constructed a generative model for de novo PIM-2 inhibitor design based on artificial intelligence, performed molecular docking and molecular dynamics (MD) simulations to develop an efficient PIM-2 inhibitor generative model and discover potential PIM-2 inhibitors.
View Article and Find Full Text PDFPIM kinase inhibitors: an updated patent review (2016-present).
Expert Opin Ther Pat
May 2024
Department of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, India.
Article Synopsis
- PIM kinases (PIM-1, PIM-2, PIM-3) are important for cell survival and proliferation, and their over-expression is linked to various blood cancers, suggesting they could be effective biomarkers and treatment targets in personalized cancer therapies.
- Recent research emphasizes the development of specific inhibitors for these kinases, which have shown positive effects in patients with advanced and hard-to-treat cancers.
- A review of literature from 2016 to the present covers the role of PIM kinases in cancer development as well as detailed insights into the pharmacology and structure of newly patented inhibitors, highlighting their potential for cancer treatment.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!